• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基糖苷类药物清除率可较好地估算重症监护病房患者的肌酐清除率。

Aminoglycoside clearance is a good estimate of creatinine clearance in intensive care unit patients.

作者信息

Jones T E, Peter J V, Field J

机构信息

Intensive Care Unit, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.

出版信息

Anaesth Intensive Care. 2009 Nov;37(6):944-52. doi: 10.1177/0310057X0903700611.

DOI:10.1177/0310057X0903700611
PMID:20014601
Abstract

The aim of this study was to determine whether creatinine clearance can be estimated as well by clearance of gentamicin/tobramycin as by routine, non-invasive estimates in the intensive care unit. The volume of distribution and clearance values for gentamicin/tobramycin were obtained using first order kinetics and an estimate of creatinine clearance derived. Seven estimates of renal function (Cockroft-Gault, MDRD4 and MDRD6 equations, two- and 24-hour urine estimates, two equations utilising Cystatin C concentrations) were compared to the gentamicin/tobramycin clearance estimate in 100 intensive care unit patients. The gentamicin clearance estimate was at least as reliable as other estimates. The two-hour was less reliable than the 24-hour urine estimate. The Cockroft-Gault appeared to out-perform the MDRD equation estimates. The MDRD4 was not as reliable as the MDRD6 estimate. Cystatin C estimates appeared not as reliable as the gentamicin estimate of renal function. The gentamicin/tobramycin estimate is at least as good as other estimates and it is available sooner than most others. It should be used in all patients who are prescribed gentamicin. The two-hour urine and MDRD4 estimates should not be used in the intensive care unit.

摘要

本研究的目的是确定在重症监护病房中,庆大霉素/妥布霉素清除率对肌酐清除率的估算效果是否与常规非侵入性估算方法一样好。使用一级动力学方法获取庆大霉素/妥布霉素的分布容积和清除率值,并得出肌酐清除率的估算值。在100例重症监护病房患者中,将七种肾功能估算方法(Cockroft-Gault公式、MDRD4和MDRD6方程、两小时和24小时尿估算方法、两种利用胱抑素C浓度的方程)与庆大霉素/妥布霉素清除率估算值进行了比较。庆大霉素清除率估算值至少与其他估算方法一样可靠。两小时尿估算方法不如24小时尿估算方法可靠。Cockroft-Gault公式似乎比MDRD方程估算方法表现更好。MDRD4不如MDRD6估算方法可靠。胱抑素C估算方法似乎不如庆大霉素对肾功能的估算方法可靠。庆大霉素/妥布霉素估算方法至少与其他估算方法一样好,而且比大多数其他方法能更快得出结果。所有使用庆大霉素的患者都应采用该方法。两小时尿估算方法和MDRD4估算方法不应在重症监护病房中使用。

相似文献

1
Aminoglycoside clearance is a good estimate of creatinine clearance in intensive care unit patients.氨基糖苷类药物清除率可较好地估算重症监护病房患者的肌酐清除率。
Anaesth Intensive Care. 2009 Nov;37(6):944-52. doi: 10.1177/0310057X0903700611.
2
Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.评估氨基糖苷类药物剂量及估算肾小球滤过率对确定庆大霉素和妥布霉素曲线下面积及清除率的作用。
Intern Med J. 2015 Mar;45(3):319-29. doi: 10.1111/imj.12684.
3
Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.肾脏疾病饮食调整及改良的Cockcroft-Gault公式在预测氨基糖苷类药物清除方面的应用
Ann Pharmacother. 2008 Dec;42(12):1758-65. doi: 10.1345/aph.1L144.
4
Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.血清胱抑素C用于在调整阿米卡星、庆大霉素、妥布霉素和万古霉素剂量时预测肾小球滤过率。
Ther Drug Monit. 2006 Jun;28(3):326-31. doi: 10.1097/01.ftd.0000211805.89440.3d.
5
Predictive performance of glomerular filtration rate estimation equations based on cystatin C versus serum creatinine values in critically ill patients.基于胱抑素C与血清肌酐值的肾小球滤过率估计方程在危重症患者中的预测性能
Am J Health Syst Pharm. 2016 Feb 15;73(4):206-15. doi: 10.2146/ajhp140852.
6
Single-dose gentamicin clearance is a predictor of creatinine clearance in spinal man.单次剂量庆大霉素清除率是脊髓损伤患者肌酐清除率的预测指标。
Am J Ther. 2010 Jul-Aug;17(4):390-5. doi: 10.1097/MJT.0b013e3181a75c84.
7
Suboptimal aminoglycoside dosing in critically ill patients.危重症患者氨基糖苷类药物剂量不足
Ther Drug Monit. 2008 Dec;30(6):674-81. doi: 10.1097/FTD.0b013e31818b6b2f.
8
Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.危重症患者中庆大霉素浓度的影响因素:群体药代动力学分析。
Int J Antimicrob Agents. 2017 Feb;49(2):204-211. doi: 10.1016/j.ijantimicag.2016.10.022. Epub 2016 Dec 16.
9
The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance.Cockcroft-Gault 方程、改良肾脏病饮食研究方程和慢性肾脏病流行病学合作方程在预测庆大霉素清除率方面的表现。
Ann Clin Biochem. 2013 Nov;50(Pt 6):546-57. doi: 10.1177/0004563213492320. Epub 2013 Sep 17.
10
[Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].[危重症患者每日一次氨基糖苷类药物治疗的血清水平调整剂量:一项前瞻性研究的结果]
Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 May;34(5):288-95. doi: 10.1055/s-1999-186.

引用本文的文献

1
Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients.利用庆大霉素浓度评估重症监护病房患者的肾小球滤过率。
Sci Rep. 2025 May 18;15(1):17262. doi: 10.1038/s41598-025-01256-z.
2
Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options.临床实践中氨基糖苷类药物相关的肾毒性和耳毒性:病理生理机制及治疗选择综述
Adv Ther. 2023 Apr;40(4):1357-1365. doi: 10.1007/s12325-023-02436-x. Epub 2023 Feb 4.
3
A More Accurate Method to Estimate Aminoglycoside Clearance From Serum Creatinine in Patients With Spinal Cord Injury.
一种更准确的从脊髓损伤患者血清肌酐估算氨基糖苷类药物清除率的方法。
J Pharm Technol. 2015 Jun;31(3):115-119. doi: 10.1177/8755122514559844. Epub 2014 Nov 21.
4
Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis.氨基糖苷类药物药代动力学与与器官功能障碍相关的生物学参数的关系:腹腔感染危重症患者的病例系列研究。
Eur J Hosp Pharm. 2022 Mar;29(e1):e72-e76. doi: 10.1136/ejhpharm-2021-003089. Epub 2021 Nov 11.
5
Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin.使用氨基糖苷类药物的谷浓度和尿中性粒细胞明胶酶相关脂质运载蛋白检测危重症老年患者亚临床肾毒性。
Eur J Hosp Pharm. 2022 Mar;29(e1):e63-e66. doi: 10.1136/ejhpharm-2021-002868. Epub 2021 Jul 20.
6
Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?儿科重症监护中的增强肾清除率:我们是否对病情最严重的患者治疗不足?
Pediatr Nephrol. 2020 Jan;35(1):25-39. doi: 10.1007/s00467-018-4120-2. Epub 2018 Oct 29.
7
Estimation of renal function in the intensive care unit: the covert concepts brought to light.重症监护病房肾功能评估:隐性概念浮出水面。
J Intensive Care. 2014 May 7;2(1):31. doi: 10.1186/2052-0492-2-31. eCollection 2014.
8
Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model.肥胖和性别对抗菌药物药代动力学和急性肾损伤的影响:临床前模型的验证。
Antimicrob Agents Chemother. 2013 Feb;57(2):716-22. doi: 10.1128/AAC.01194-12. Epub 2012 Nov 12.
9
Should monitoring of vancomycin be delayed? A case of likely nephrotoxicity occasioned by morbid obesity and minimal monitoring.万古霉素监测是否应推迟?一例由病态肥胖和极少监测引发的可能的肾毒性病例。
Br J Clin Pharmacol. 2012 Dec;74(6):1063-5. doi: 10.1111/j.1365-2125.2011.04006.x.